DM and MS Flashcards
Impaired Fasting Glucose
FPG 100-125
Impaired Glucose Tolerance
Based on result of 2h OGTT
140-199
Hba1c Prediabetes Range
5.7-6.4%
Hba1c level diagnostic for DM
6.5% or greater
Goal Hba1c for a diabetic pt (ADA)
less than 7%
In US, DM is leading cause of (3)
non-traumatic amputations
blindness
end stage renal disease
Preferred diagnostic test for DM
Fasting Plasma Glucose (after 8 hour fast) venous or cap stick
Diagnostic Criteria for DM
Classic s/s hyperglycemia plus random BG 200+
Hba1c 6.5% or higher
FPG 126 or higher
2 hour OGTT of 200 or higher
who is recommended to do SMBG
all insulin-treated DM pts
pts on sulfonylureas
pts not achieving glycemic control goals.
Type 1 pts should SMBG
3-4x/day
type 1 pts should test urine ketones when
during acute illness
when BG consistently elevated
s/s DKA are present
DM pt should not exercise when
BG 250
ketones positive
Type 1 pt should eat before exercise
15g CHO before moderate activity
more food for more activity
who should carry a readily-absorbable CHO on person
Type 1
pts on sulfonylureas or meglinitides
ADA recommended BG for DM pts before and after meals
before: 90-130
after: less than 180
drugs that can antagonize (oppose) hypoglycemic effects of insulin
corticosteroids
thiazide/loop diuretics
sympathomimetics
thyroid hormone
drugs than can increase hypoglycemic effects of insulin
alcohol
anabolic steroids
MAOIs
salicylates
can mask tachycardia from hypoglycemia
nonselective beta blockers
Peak action of rapid-acting insulin
1 hour
Duration of action of rapid-acting insulin
3-4 hours
Three types of rapid-acting insulin
Apidra (glulisine)
Humalog (lispro)
Novolog (aspart)
Onset of short-acting (regular) insulin
30 min-1 hour
Peak of action of short-acting (regular) insulin
2-4 hours
Duration of action of short-acting (regular) insulin
6-8 hours
Types of short-acting (regular) insulin
Novolin R
Humulin R
Onset of Intermediate-Acting (NPH) insulin
1-3 hours
Peak of Action of Intermediate-Acting (NPH) insulin
6-8 hours
Duration of action of Intermediate-Acting (NPH) insulin
12-16 hours
Types of Intermediate-Acting (NPH) insulin
Novolin N
Humulin N
Onset of Action of Long-Acting insulin
2-6 hours
Peak of Action of Long-Acting insulin
none
Duration of Action of Long-Acting insulin
12- 24 hours
DCCT
Diabetes Control and Complications Trial
Demonstrated intensive glucose control dramatically reduced the development and progression of complications; also increased risk of hypoglycemia
UKPDS-UK Prospective Study
demonstrated a decrease in complications in patients who had Type 2 DM
alcohol consumption is dangerous in DM pts (especially those on insulin) because
alcohol inhibits gluconeogenesis and can cause hypoglycemia
May also impair ability to recognize and treat HoG
swan neck deformity
affects most distal joint of finger, occurs in RA
ulnar deviation, drift
all fingers angle toward ulnar side, occurs in arthritis
Valgus deformities
distal arm of joint points away from midline (brings joints closer)
Bunion
Hallux valgus deformity of big toe
Genu valgum
Valgus deformity of knees (together)
Talipes valgus
Eversion of feet (walk on instep)
Varus deformities
distal arm of joint points toward midline (moves joints apart)
Talipes varus
inversion of feet
Genu varum
bow legs
Lordosis
exaggerated curvature of lumbar spine; “sway back”; often in pregnant women
Scoliosis
lateral curvature of spine, increased when bending forward
Kyphosis
increased curvature of thoracic spine; often in elderly with OA
Pes planus
flat foot